drugset / Trial / NCT02868424
Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation
NaSingle-groupOpen-labelTreatment
Summary
Early Phase I Study of the Safety and Preliminary Efficacy of Human Fetal Retinal Pigment Epithelial(fRPE) Cells Subretinal Transplantation in Age-Related Macular Degeneration(AMD) Patients
Timeline
- Start
- 2016-02-13
- Primary completion
- 2018-08
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fRPE cells | Cell therapy | 100000 cells | Other |
| Subject | fRPE cells | Cell therapy | 200000 cells | Other |
| Subject | fRPE cells | Cell therapy | 500000 cells | Other |